NCT02152761 - Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery | Biotech Hunter

Enrollment

251

Participants

Timeline

Start Date

September 16, 2014

Primary Completion Date

May 14, 2018

Study Completion Date

October 25, 2018

Conditions

Muscle Wasting (Atrophy) After Hip Fracture Surgery

Interventions

DRUG

bimagrumab

Bimagrumab was administered as intravenous infusion starting on Day 1 until week 20.

OTHER

placebo

Matching placebo was administered as intravenous infusion starting on Day 1 until week 20.

Trial Locations (53)

1062

Novartis Investigative Site, Budapest

1125

Novartis Investigative Site, Budapest

1211

Novartis Investigative Site, Geneva

3000

Novartis Investigative Site, Hatvan

3600

Novartis Investigative Site, Genk

5041

Novartis Investigative Site, Bedford Park

8000

Novartis Investigative Site, Bruges

9000

Novartis Investigative Site, Ghent

10021

Novartis Investigative Site, New York

11217

Novartis Investigative Site, Taipei

20127

Novartis Investigative Site, Aguascalientes

28049

Novartis Investigative Site, Madrid

30450

Novartis Investigative Site, Pilsen

30501

Novartis Investigative Site, Gainesville

33305

Novartis Investigative Site, Taoyuan District

34093

Novartis Investigative Site, Istanbul

34295

Novartis Investigative Site, Montpellier

35040

Novartis Investigative Site, Izmir

39110

Novartis Investigative Site, Magdeburg

41014

Novartis Investigative Site, Seville

55905

Novartis Investigative Site, Rochester

59037

Novartis Investigative Site, Lille

66250

Novartis Investigative Site, Brno

78200

Novartis Investigative Site, San Luis Potosí City

80210

Novartis Investigative Site, Denver

82445

Novartis Investigative Site, Kaohsiung City

85023

Novartis Investigative Site, Phoenix

92020

Novartis Investigative Site, El Cajon

93077

Novartis Investigative Site, Bad Abbach

97074

Novartis Investigative Site, Würzburg

150003

Novartis Investigative Site, Yaroslavl

190103

Novartis Investigative Site, Saint Petersburg

196143

Novartis Investigative Site, Saint Petersburg

197706

Novartis Investigative Site, Sestroretsk

C1128AAF

Novartis Investigative Site, Ciudad Autonoma de Bs As

80 10

Novartis Investigative Site, Graz

838 0456

Novartis Investigative Site, Santiago

Unknown

Novartis Investigative Site, Santiago de Cali

Novartis Investigative Site, Barranquilla

500 05

Novartis Investigative Site, Hradec Králové

532 03

Novartis Investigative Site, Pardubice

150 06

Novartis Investigative Site, Prague

100 34

Novartis Investigative Site, Prague

01307

Novartis Investigative Site, Dresden

662-0918

Novartis Investigative Site, Nishinomiya

247-8533

Novartis Investigative Site, Kamakura

780-8522

Novartis Investigative Site, Kochi

862-0976

Novartis Investigative Site, Kumamoto

701-1192

Novartis Investigative Site, Okayama

939-8511

Novartis Investigative Site, Toyama

08035

Novartis Investigative Site, Barcelona

08036

Novartis Investigative Site, Barcelona

BA1 3NG

Novartis Investigative Site, Bath